Synthesis and biological activities of some 1, 3, 4-thiadiazine derivatives
Öz
Anahtar Kelimeler
Destekleyen Kurum
Teşekkür
Kaynakça
- [1] M. Dinarvand and M. Spain, ‘‘Identification of bioactive compounds from marine natural products and exploration of structure-activity relationships (sar),’’ Antibiotics, vol. 10, no. 3, p. 337, 2021.
- [2] E. Bentivegna, M. Luciani, L. Arcari, I. Santino, M. Simmaco, and P. Martelletti, ‘‘Reduction of multidrug-resistant (mdr) bacterial infections during the covid-19 pandemic: a retrospective study,’’ International journal of environmental research and public health, vol. 18, no. 3, p. 1003, 2021.
- [3] T. M. Terreni, Marco and M. Pregnolato, ‘‘New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives,’’ Molecules, vol. 26, no. 9, p. 2671, 2021.
- [4] P. C. Jilloju, L. Persoons, S. K. Kurapati, D. Schols, S. De Jonghe, D. Daelemans, and R. R. Vedula, ‘‘Discovery of (±)-3-(1 h-pyrazol-1-yl)-6, 7-dihydro-5 h-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity,’’ Molecular Diversity, vol. 26, no. 3, pp. 1357–1371, 2022.
- [5] S. Chhabra and K. Shah, ‘‘The novel scaffold 1, 2, 4-benzothiadiazine-1, 1-dioxide: a review,’’ Medicinal Chemistry Research, vol. 30, pp. 15–30, 2021.
- [6] C. Kamoutsis, M. Fesatidou, A. Petrou, A. Geronikaki, V. Poroikov, M. Ivanov, M. Soković, A. Ćirić, A. Carazo, and P. Mladěnka, ‘‘Triazolo based-thiadiazole derivatives. synthesis, biological evaluation and molecular docking studies,’’ Antibiotics, vol. 10, no. 7, p. 804, 2021.
- [7] F. Hassanzadeh, E. Jafari, F. Shojaei, and H. Sadeghi-Aliabadi, ‘‘Synthesis and cytotoxic activity evaluation of some new 1, 3, 4-oxadiazole, 1, 3, 4-thiadiazole and 1, 2, 4-triazole derivatives attached to phthalimide,’’ Research in Pharmaceutical Sciences, vol. 16, no. 6, pp. 634–642, 2021.
- [8] A. M. A. Ouf, H. A. Allam, M. Kamel, F. A. Ragab, and S. A. Abdel-Aziz, ‘‘Design, synthesis, cytotoxic and enzyme inhibitory activities of 1, 3, 4-oxadiazole and 1, 3, 4-thiadiazine hybrids against non-small cell lung cancer,’’ Results in Chemistry, vol. 4, p. 100373, 2022.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Mühendislik Uygulaması
Bölüm
Araştırma Makalesi
Yazarlar
Erdal Kocabaş
*
0000-0002-0980-0894
Türkiye
Deniz Tuğçe Algan
0000-0002-0085-4327
Türkiye
Fatih Erci
0000-0002-3044-7343
Türkiye
Yayımlanma Tarihi
1 Mayıs 2025
Gönderilme Tarihi
22 Temmuz 2024
Kabul Tarihi
25 Kasım 2024
Yayımlandığı Sayı
Yıl 2025 Cilt: 12 Sayı: 2


